Developer docs
API playgroundTry for free, no card

Search company profiles

TJM Labs

Full company profile

uuid00pyk6j

Namestring
TJM Labs
Legal namestring
TJM Labs, LLC
Websiteurl
tjmlabs.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

TJM Labs is a private, Delaware-incorporated AI software company that automates repetitive workflows inside pharmacies without replacing existing systems. Its platform pairs licensed pharmacists with automation engineers under a Dual-Expert Model and uses computer vision and large language models to drive bots directly through pharmacy management system interfaces (BestRx, PioneerRx, PrimeRx, QS/1, Liberty, Scriptly, RedSail, TELUS Health, Pharmetika, SiCompounding), avoiding API or rip-and-replace integration. The product portfolio spans TJM Bot (prescription intake, data entry, refills, prior authorizations), TJM Retail Bot (plug-and-play for independent pharmacies), VoiceAI (24/7 patient phone automation), Provider Portal (structured prescription submission for compounders), and the acquired Pharmesol voice platform.

The company serves four primary verticals (compounding, specialty, long-term care, and retail/independent pharmacies) across the US and Canada, claiming support for 400+ pharmacies and 300,000+ prescriptions processed daily through its PCCA channel partnership alone. Named enterprise customers include Gifthealth (25,000+ prescriptions/day, 150 active bots, $25M annual savings reported), LinkRx (6,640 prescriptions/day, 10x ROI), Zeal Specialty Pharmacy, Walberg Family Pharmacies, and Triangle, Valor, and VEPO compounding operations.

TJM Labs monetizes through a mix of custom multi-year enterprise contracts (with forward-deployed engineers, dedicated teams, custom SLAs, and multi-product bundling) and a publicly priced Provider Portal subscription (Starter $299/month up to a custom tier above 6,000 scripts/month). Enterprise economics are anchor-driven, with 50% of revenue from 10 enterprise customers covering 200+ locations and 3M+ scripts per month. The company raised a $10M Series A led by Arthur Ventures in November 2025 (first sale December 19, 2025) at a $20M post-money valuation, has 70 employees across four regions, and is HIPAA-compliant with SOC 2 Type 2 and HITRUST CSF posture.

Short descriptiontext

TJM Labs is an AI-powered pharmacy automation company that uses Vision AI and a pharmacist-plus-engineer delivery model to automate prescription intake, data entry, refills, and patient calls across 400+ compounding, specialty, long-term care, and retail pharmacies in the US and Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBear, United States
HQ citystring
Bear
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy automation software, AI-powered prescription bots, pharmacy workflow automation, Vision AI pharmacy systems, compounding pharmacy software
Industry2 codes
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
Product category
Pharmacy Automation Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscription - Provider Portal
TypeSubscription Recurring
Description

Monthly subscription pricing based on prescription volume with three tiers (Starter, Growth, Scale) plus custom enterprise pricing. No setup fees. Includes catalog setup and provider onboarding.

tjmlabs.com
2Enterprise Automation Contracts
TypeSubscription Recurring
Description

Custom enterprise contracts with forward-deployed engineers, dedicated teams, and custom SLAs. 50% of revenue from 10 enterprise customers with 200+ locations served. Multiple products (TJM Bot, VoiceAI, Provider Portal) deployed together.

tjmlabs.com
3Series A Investment
TypeSubscription Recurring
Description

Raised $10 million in Series A funding led by Arthur Ventures in November 2025, with first sale on December 19, 2025.

tjmlabs.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Starter: $299/month for 1,000 scripts/month
ModelSubscriptionBilling cadenceMonthly
Notes

Entry-level tier for smaller compounding pharmacies. Includes catalog setup and provider onboarding with no setup fees.

tjmlabs.com
2Growth: $799/month for 3,000 scripts/month
ModelSubscriptionBilling cadenceMonthly
Notes

Mid-tier option for growing compounding pharmacies with increased prescription volume.

tjmlabs.com
3Scale: $1,499/month for 6,000 scripts/month
ModelSubscriptionBilling cadenceMonthly
Notes

High-volume tier for established compounding pharmacies processing significant prescription loads.

tjmlabs.com
4Custom: Contact sales for 6,000+ scripts/month
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom pricing for enterprise-level pharmacies with volumes exceeding 6,000 scripts monthly. Includes all Scale features plus custom integrations and dedicated support.

tjmlabs.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1TJM Bot
Description

AI-powered automation bot for prescription intake, data entry, and pharmacy workflow automation.

tjmlabs.com
+5 more records
Core offering1 text field

TJM Labs sells an AI-powered pharmacy automation platform that uses Vision AI to interact directly with existing pharmacy management system (PMS) interfaces, automating prescription intake, data entry, refill processing, prior authorizations, and patient phone communications. The platform comprises TJM Bot, TJM Retail Bot, Provider Portal, and VoiceAI, sold as subscription SaaS to compounding, specialty, long-term care, and retail/independent pharmacies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 10x ROI on automation investment for specialty compounding pharmacies
+9 more records
Product overview1 text field

TJM Labs offers a unified AI-powered pharmacy automation platform designed to automate repetitive pharmacy tasks without replacing existing systems. The core portfolio consists of TJM Bot (primary automation for prescription intake and data entry), TJM Retail Bot (for retail pharmacy), VoiceAI (24/7 phone automation for patient communications), and Provider Portal (structured prescription submission). These products work independently or together as integrated modules, powered by the Dual-Expert Model that pairs pharmacists with engineers. TJM Labs serves compounding, specialty, long-term care, retail, and independent pharmacies across the US and Canada, processing over 3 million prescriptions monthly.

Product and service4 records
1TJM Bot
CategoryPharmacy Automation Software
Description

AI-powered automation bot that handles prescription intake, data entry, refill processing, prior authorizations, and patient communications by working through existing pharmacy management system interfaces via Vision AI, eliminating the need for APIs or system replacements. Targeted at compounding, specialty, and large-scale pharmacy operations.

2TJM Retail Bot
CategoryPharmacy Automation Software
Description

Plug-and-play automation bot designed for retail and independent pharmacy workflows requiring no customization and going live in days; automates prescription intake, refill management, and patient communication for independent and retail pharmacies.

3Provider Portal
CategoryPharmacy Automation Software
Description

White-labeled, structured prescription submission portal for compounding pharmacies that lets providers submit clean scripts in 30 seconds via a three-tap process, eliminating fax deciphering and manual re-keying; delivered as subscription tiers based on monthly prescription volume.

4VoiceAI
CategoryPharmacy Automation Software
Description

AI-powered voice automation that handles inbound and outbound pharmacy calls 24/7 with natural conversation (no phone trees), processing refill requests, order status, appointment confirmations, and patient communications; HIPAA-compliant and URAC-compliant for specialty pharmacy.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1PCCA (Professional Compounding Centers of America)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-28
Description

PCCA, a 45-year-old Houston-based provider of compounding pharmacy products and support, named TJM Labs its official automation partner. TJM Labs provides AI-powered workflow automation including AI bots for prescription intake, data entry, prior authorizations, and patient communication to PCCA's member pharmacies. Partnership gives PCCA members access to technology supporting over 400 pharmacies processing more than 300,000 prescriptions daily.

financialcontent.com
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-11-07
Description

Corporate Patron partnership with APC, the leading voice representing the pharmacy compounding profession. TJM Labs engages with APC members and stakeholders to support best practices and continuous improvement. Team members actively involved across APC committees, working groups, and knowledge-sharing opportunities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Nationwide prescription data network and clinical messaging backbone for pharmacies, providers, and PBMs. Sits at the rail layer TJM Labs' bots traverse, making it both a potential partner and a competitor as it expands into workflow automation.

TypeDirect peer
Description

ePrescribing and medication management software purpose-built for pharmacies, dental, and ambulatory practices. Closely comparable in automating prescription workflows for pharmacy operators, with overlapping target buyer personas.

TypeEmerging player
Description

Pharmacy automation hardware and workflow software provider focused on adherence packaging and dispensing. Smaller scale than Omnicell/ScriptPro but competes for the same pharmacy technology wallet.

TypeDirect peer
Description

ePrescribing, clinical messaging, and medication management platform used by pharmacies and providers. Comparable in automating prescription intake and clinical data workflows, though historically API/integration-led rather than Vision AI.

5CoverMyMeds (McKesson)
TypeDirect peer
Description

McKesson-owned prior authorization and medication management platform serving pharmacies, providers, and payers. Direct overlap with TJM Labs' prior authorization and patient communication automation, but with a broader, incumbent footprint.

TypeBroad incumbent
Description

Pharmacy workflow, dispensing, and robotic automation vendor serving retail and hospital pharmacies. Comparable pharmacy automation category but historically focused on dispensing robotics rather than AI workflow agents.

TypeBroad incumbent
Description

Large pharmacy automation and medication management company spanning hardware, software, and adherence packaging. Broader incumbent portfolio than TJM Labs' software-only stack but competes for pharmacy automation budgets.

TypeEmerging player
Description

Pharmacy clinical services and medication management platform serving health systems and pharmacies. Adjacent overlap in clinical pharmacy workflow automation, particularly for specialty and hospital-adjacent pharmacies.

9Innovation Associates (Omnicell)
TypeBroad incumbent
Description

Pharmacy central fill and high-volume dispensing automation now part of Omnicell. Comparable in automating high-volume pharmacy workflows, though anchored to large-scale central fill operations.

TypeRegional player
Description

Prescription pickup and dispensing kiosk automation vendor, now part of Veradigm (Allscripts). Less directly overlapping on AI workflow automation but competes for pharmacy technology budgets at the point of dispensing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TJM Labs

Pharmacy Automation Softwaretjmlabs.com

TJM Labs is an AI-powered pharmacy automation company that uses Vision AI and a pharmacist-plus-engineer delivery model to automate prescription intake, data entry, refills, and patient calls across 400+ compounding, specialty, long-term care, and retail pharmacies in the US and Canada.

What TJM Labs does

TJM Labs is a private, Delaware-incorporated AI software company that automates repetitive workflows inside pharmacies without replacing existing systems. Its platform pairs licensed pharmacists with automation engineers under a Dual-Expert Model and uses computer vision and large language models to drive bots directly through pharmacy management system interfaces (BestRx, PioneerRx, PrimeRx, QS/1, Liberty, Scriptly, RedSail, TELUS Health, Pharmetika, SiCompounding), avoiding API or rip-and-replace integration. The product portfolio spans TJM Bot (prescription intake, data entry, refills, prior authorizations), TJM Retail Bot (plug-and-play for independent pharmacies), VoiceAI (24/7 patient phone automation), Provider Portal (structured prescription submission for compounders), and the acquired Pharmesol voice platform.

The company serves four primary verticals (compounding, specialty, long-term care, and retail/independent pharmacies) across the US and Canada, claiming support for 400+ pharmacies and 300,000+ prescriptions processed daily through its PCCA channel partnership alone. Named enterprise customers include Gifthealth (25,000+ prescriptions/day, 150 active bots, $25M annual savings reported), LinkRx (6,640 prescriptions/day, 10x ROI), Zeal Specialty Pharmacy, Walberg Family Pharmacies, and Triangle, Valor, and VEPO compounding operations.

TJM Labs monetizes through a mix of custom multi-year enterprise contracts (with forward-deployed engineers, dedicated teams, custom SLAs, and multi-product bundling) and a publicly priced Provider Portal subscription (Starter $299/month up to a custom tier above 6,000 scripts/month). Enterprise economics are anchor-driven, with 50% of revenue from 10 enterprise customers covering 200+ locations and 3M+ scripts per month. The company raised a $10M Series A led by Arthur Ventures in November 2025 (first sale December 19, 2025) at a $20M post-money valuation, has 70 employees across four regions, and is HIPAA-compliant with SOC 2 Type 2 and HITRUST CSF posture.

TJM Labs firmographics

Firmographics
Name
TJM Labs
Legal name
TJM Labs, LLC
Website
https://tjmlabs.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
101–250 employees
Short description
TJM Labs is an AI-powered pharmacy automation company that uses Vision AI and a pharmacist-plus-engineer delivery model to automate prescription intake, data entry, refills, and patient calls across 400+ compounding, specialty, long-term care, and retail pharmacies in the US and Canada.
Ownership category
akta.pro rank

TJM Labs industry classification

Industry
Product category
Pharmacy Automation Software
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
akta.pro industry
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Pharmacy automation software
  • AI-powered prescription bots
  • Pharmacy workflow automation
  • Vision AI pharmacy systems
  • Compounding pharmacy software

Where TJM Labs is headquartered

Location

Headquarters

HQ city
Bear
HQ country
United States
HQ region
North America

Offices1 record

Markets served

TJM Labs business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SaaS Subscription - Provider Portal: Monthly subscription pricing based on prescription volume with three tiers (Starter, Growth, Scale) plus custom enterprise pricing. No setup fees. Includes catalog setup and provider onboarding.
  2. Enterprise Automation Contracts: Custom enterprise contracts with forward-deployed engineers, dedicated teams, and custom SLAs. 50% of revenue from 10 enterprise customers with 200+ locations served. Multiple products (TJM Bot, VoiceAI, Provider Portal) deployed together.
  3. Series A Investment: Raised $10 million in Series A funding led by Arthur Ventures in November 2025, with first sale on December 19, 2025.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStarter: $299/month for 1,000 scripts/month
SubscriptionMonthlyGrowth: $799/month for 3,000 scripts/month
SubscriptionMonthlyScale: $1,499/month for 6,000 scripts/month
SubscriptionMulti-year contractCustom: Contact sales for 6,000+ scripts/month

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

TJM Labs product offering

Product offering

Core offering

TJM Labs sells an AI-powered pharmacy automation platform that uses Vision AI to interact directly with existing pharmacy management system (PMS) interfaces, automating prescription intake, data entry, refill processing, prior authorizations, and patient phone communications. The platform comprises TJM Bot, TJM Retail Bot, Provider Portal, and VoiceAI, sold as subscription SaaS to compounding, specialty, long-term care, and retail/independent pharmacies.

Product overview

TJM Labs offers a unified AI-powered pharmacy automation platform designed to automate repetitive pharmacy tasks without replacing existing systems. The core portfolio consists of TJM Bot (primary automation for prescription intake and data entry), TJM Retail Bot (for retail pharmacy), VoiceAI (24/7 phone automation for patient communications), and Provider Portal (structured prescription submission). These products work independently or together as integrated modules, powered by the Dual-Expert Model that pairs pharmacists with engineers. TJM Labs serves compounding, specialty, long-term care, retail, and independent pharmacies across the US and Canada, processing over 3 million prescriptions monthly.

Differentiator

Problem solved

Functional benefit

Brands

  • TJM Bot: AI-powered automation bot for prescription intake, data entry, and pharmacy workflow automation.
  • TJM Retail Bot
  • Provider Portal
  • VoiceAI
  • TJM Portal
  • Pharmesol

Products and services

  • TJM Bot AI-powered automation bot that handles prescription intake, data entry, refill processing, prior authorizations, and patient communications by working through existing pharmacy management system interfaces via Vision AI, eliminating the need for APIs or system replacements. Targeted at compounding, specialty, and large-scale pharmacy operations.
  • TJM Retail Bot Plug-and-play automation bot designed for retail and independent pharmacy workflows requiring no customization and going live in days; automates prescription intake, refill management, and patient communication for independent and retail pharmacies.
  • Provider Portal White-labeled, structured prescription submission portal for compounding pharmacies that lets providers submit clean scripts in 30 seconds via a three-tap process, eliminating fax deciphering and manual re-keying; delivered as subscription tiers based on monthly prescription volume.
  • VoiceAI AI-powered voice automation that handles inbound and outbound pharmacy calls 24/7 with natural conversation (no phone trees), processing refill requests, order status, appointment confirmations, and patient communications; HIPAA-compliant and URAC-compliant for specialty pharmacy.

Quantifiable outcome

  • 10x ROI on automation investment for specialty compounding pharmacies
  • +9 more outcomes

Companies that use TJM Labs

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles4 records

TJM Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability9 records

Feature6 records

TJM Labs partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • PCCA (Professional Compounding Centers of America)coreChannel Partner/ Reseller/ Distributor · 28 May 2026PCCA, a 45-year-old Houston-based provider of compounding pharmacy products and support, named TJM Labs its official automation partner. TJM Labs provides AI-powered workflow automation including AI bots for prescription intake, data entry, prior authorizations, and patient communication to PCCA's member pharmacies. Partnership gives PCCA members access to technology supporting over 400 pharmacies processing more than 300,000 prescriptions daily.
  • Alliance for Pharmacy Compounding (APC)minorGTM or Marketing Partner · 7 November 2025Corporate Patron partnership with APC, the leading voice representing the pharmacy compounding profession. TJM Labs engages with APC members and stakeholders to support best practices and continuous improvement. Team members actively involved across APC committees, working groups, and knowledge-sharing opportunities.

Scale indicators7 records

Recent moves6 records

Expansion highlights3 records

TJM Labs competitors and assessment

Company assessment

Broad incumbents

  • Surescripts: Nationwide prescription data network and clinical messaging backbone for pharmacies, providers, and PBMs. Sits at the rail layer TJM Labs' bots traverse, making it both a potential partner and a competitor as it expands into workflow automation.
  • ScriptPro: Pharmacy workflow, dispensing, and robotic automation vendor serving retail and hospital pharmacies. Comparable pharmacy automation category but historically focused on dispensing robotics rather than AI workflow agents.
  • Omnicell: Large pharmacy automation and medication management company spanning hardware, software, and adherence packaging. Broader incumbent portfolio than TJM Labs' software-only stack but competes for pharmacy automation budgets.
  • Innovation Associates (Omnicell): Pharmacy central fill and high-volume dispensing automation now part of Omnicell. Comparable in automating high-volume pharmacy workflows, though anchored to large-scale central fill operations.

Direct peers

  • DoseSpot: ePrescribing and medication management software purpose-built for pharmacies, dental, and ambulatory practices. Closely comparable in automating prescription workflows for pharmacy operators, with overlapping target buyer personas.
  • DrFirst: ePrescribing, clinical messaging, and medication management platform used by pharmacies and providers. Comparable in automating prescription intake and clinical data workflows, though historically API/integration-led rather than Vision AI.
  • CoverMyMeds (McKesson): McKesson-owned prior authorization and medication management platform serving pharmacies, providers, and payers. Direct overlap with TJM Labs' prior authorization and patient communication automation, but with a broader, incumbent footprint.

Emerging players

  • RxSafe: Pharmacy automation hardware and workflow software provider focused on adherence packaging and dispensing. Smaller scale than Omnicell/ScriptPro but competes for the same pharmacy technology wallet.
  • PipelineRx (Cureatr): Pharmacy clinical services and medication management platform serving health systems and pharmacies. Adjacent overlap in clinical pharmacy workflow automation, particularly for specialty and hospital-adjacent pharmacies.

Regional players

  • Asteres (Veradigm): Prescription pickup and dispensing kiosk automation vendor, now part of Veradigm (Allscripts). Less directly overlapping on AI workflow automation but competes for pharmacy technology budgets at the point of dispensing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

TJM Labs social profiles

Digital presence

TJM Labs compliance and trust

Trust signal

Compliance3 records

TJM Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TJM Labs leadership team

Management profile

Number of profiles

Profiles2 records

TJM Labs subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

TJM Labs funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TJM Labs M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TJM Labs

What does TJM Labs do?

TJM Labs sells an AI-powered pharmacy automation platform that uses Vision AI to interact directly with existing pharmacy management system (PMS) interfaces, automating prescription intake, data entry, refill processing, prior authorizations, and patient phone communications. The platform comprises TJM Bot, TJM Retail Bot, Provider Portal, and VoiceAI, sold as subscription SaaS to compounding, specialty, long-term care, and retail/independent pharmacies.

Is TJM Labs a public or private company?

TJM Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was TJM Labs founded?

TJM Labs was founded in 2024. It employs 101 to 250 people.

Where is TJM Labs based?

TJM Labs is headquartered in Bear, United States, in the North America region.

How does TJM Labs make money?

Three revenue lines are on record. SaaS Subscription - Provider Portal is the primary driver. The others are enterprise Automation Contracts and series A Investment.

Who are TJM Labs's main competitors?

Broad incumbents on record are Surescripts, ScriptPro, Omnicell and Innovation Associates (Omnicell). Direct peers are DoseSpot, DrFirst and CoverMyMeds (McKesson). Emerging players are RxSafe and PipelineRx (Cureatr). Asteres (Veradigm) is listed as a regional player.

Does TJM Labs have an API?

No public API is recorded for TJM Labs.

What industry is TJM Labs in?

TJM Labs's product category is Pharmacy Automation Software. Its primary akta.pro industry code is HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow, with a secondary code of HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems. Its NAICS code is 524292.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizTJM Labs Adds John Connolly to Board as Pharmacy AI Platform ScalesTJM Labs appointed technology executive and investor John M. Connolly as an independent board member to guide organizational design, executive development and go-to-market strategy as the pharmacy AI company scales. The company automates more than 500,000 pharmacy tasks daily across over 450 pharmacies and has raised $100 million and acquired EncoreRx and Pharmesol.EIN PresswireTJM Labs Appoints John M. Connolly as Independent Board MemberTJM Labs appointed John M. Connolly as an independent board member, bringing 30 years of experience scaling high-growth technology companies. The company's pharmacy AI platform automates over 500,000 tasks daily across 450+ pharmacies, backed by $100M in funding and acquisitions of EncoreRx and Pharmesol.EIN PresswireBioTek reMEDys Selects TJM Labs to Automate Specialty Pharmacy Benefits VerificationBioTek reMEDys selected TJM Labs to automate specialty pharmacy benefits verification, deploying AI agents to process patient documentation and create profiles. The agents currently process over 4,500 patient records weekly, and Voice AI will automate outbound payer calls. The collaboration aims to improve speed and data quality in benefits verification.EIN PresswireTJM Labs Launches Vaccine Bot Ahead of Flu Season, Expanding Its Pharmacy AI PlatformTJM Labs launched Vaccine Bot, an AI agent that automates vaccine prescription entry for pharmacies ahead of flu season. The agent charges $1 per prescription and integrates with existing pharmacy systems, with a limited initial rollout. The company's platform already serves over 450 pharmacies.TjmlabsTJM Labs Announces $100M Raised, 450+ Live Pharmacies, and Two Acquisitions as It Defines Pharmacy AITJM Labs raised $100 million across three funding rounds and announced it is live in 450+ pharmacies. The company completed acquisitions of EncoreRx and Pharmesol, expanding its pharmacy-native AI platform. Its agents process over 500,000 pharmacy tasks daily.Pulse 2.0TJM Labs Reveals $100 Million Raised Across Three Rounds, 450+ Live Pharmacies, And Two AcquisitionsTJM Labs, a pharmacy AI platform based in Wilmington, Delaware, has raised $100 million across three funding rounds in approximately six months, including a $10 million Series A, a $15 million Series A-1, and a $75 million Series B led by Elephant with participation from Arthur Ventures and Updata Partners. The company also disclosed it is now live in more than 450 pharmacies and has completed two acquisitions—EncoreRx and Pharmesol—to expand its automation and voice capabilities into a unified pharmacy-native platform. The funding and acquisitions mark TJM Labs' shift from being a "quiet operator" to positioning itself as a visible category leader as the pharmacy AI market transitions from point solutions toward enterprise-scale platforms.FinSMEsTJM Labs Raises $75M in Series B FundingTJM Labs, a pharmacy AI platform provider, raised $75M in Series B funding led by Elephant, with participation from Arthur Ventures and Updata Partners. The round follows a $10M Series A and $15M Series A-1, bringing total funding to $100M. The company will use the funds to expand operations and development.PillsburylawPillsbury Advises TJM Labs on $75 Million Series B FinancingTJM Labs raised $75 million in Series B financing led by Elephant, with participation from Arthur Ventures and Updata Partners. The company is now live in over 450 pharmacies and has acquired EncoreRx and Pharmesol, expanding its pharmacy-native AI platform. The financing underscores its emergence as a leader in pharmacy AI.The Des Moines RegisterTJM Labs Announces $100M Raised, 450+ Live Pharmacies, and Two Acquisitions as It Defines Pharmacy AITJM Labs raised $100 million across three funding rounds and announced it is live in 450+ pharmacies. Its AI agents process over 500,000 pharmacy tasks daily, and the company acquired EncoreRx and Pharmesol to expand automation and voice capabilities.EIN PresswireTJM Labs Announces $100M Raised, 450+ Live Pharmacies, and Two Acquisitions as It Defines Pharmacy AITJM Labs announced $100 million in funding across three rounds and operations in 450+ pharmacies, with AI agents processing over 500,000 tasks daily. The company also acquired EncoreRx and Pharmesol to expand its pharmacy-native platform.